World Continence Week 2025に合わせ排尿・排便障害に関する社会的理解の促進に取り組む 治療の選択肢「InterStim(TM)X」も販売開始 ―InterStim(TM)Xは、充電不要で約10年（*）の電池寿命を実現― ―2025年6月16日〜6月22日World Federation of Incontinence and Pelvic ...

announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using Medtronic InterStim® Therapy reduced incontinent episodes and increased quality ...

仙骨神経刺激療法における全身MRI対応システムを実現した 世界最小の充電式デバイス「InterStim(TM)Micro」の販売を開始 日本メドトロニック株式会社（本社:東京都港区）は、難治性の過活動膀胱または便失禁の改善を目的とした充電式仙骨神経刺激システム ...

A new multicenter study shows use of Medtronic’s InterStim Therapy via sacral nerve stimulation reduced incontinent episodes and improved quality of life in most patients with chronic fecal ...

―2025年6月16日～6月22日World Federation of Incontinence and Pelvic Problems(WFIPP)が制定した「World Continence Week」（ワールド コンチネンス ウィーク）― 日本メドトロニック株式会社（本社：東京都港区）は、過活動膀胱および便失禁の治療を目的とした仙骨神経刺激療法 ...

Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that ...

ZANESVILLE – Dr. Mitesh Parekh, a urogynecologist with Genesis Urogynecology, has been recognized by Medtronic, a medical device company, for outstanding contribution in positively impacting the lives ...

Medtronic announced it has received approval from the United States Food and Drug Administration (FDA) for expanded MRI labeling of its InterStim II and InterStim Micro sacral neuromodulation (SNM) ...

Broward Health Medical Center is now offering the InterStim X system from Medtronic, a cutting-edge treatment for patients with bladder and bowel control conditions such as urinary and fecal ...